<!DOCTYPE html>
<html lang="en">

<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Model Comparison: Opus KG-mcp vs. Opus Plain</title>
  <style>
    *,
    *::before,
    *::after {
      box-sizing: border-box;
      margin: 0;
      padding: 0;
    }

    body {
      font-family: 'Georgia', serif;
      font-size: 14px;
      color: #1a1a1a;
      background: #fff;
      padding: 48px 40px;
      max-width: 1100px;
      margin: 0 auto;
      line-height: 1.65;
    }

    header {
      border-bottom: 2px solid #1a1a1a;
      padding-bottom: 16px;
      margin-bottom: 10px;
    }

    header h1 {
      font-size: 20px;
      font-weight: bold;
      letter-spacing: 0.02em;
    }

    header p {
      font-size: 12px;
      color: #555;
      margin-top: 4px;
    }

    .legend {
      display: flex;
      gap: 24px;
      margin: 18px 0 32px;
      font-size: 12px;
      color: #444;
    }

    .legend span {
      display: flex;
      align-items: center;
      gap: 6px;
    }

    .legend-dot {
      width: 10px;
      height: 10px;
      border-radius: 50%;
      display: inline-block;
    }

    .dot-kg {
      background: #2a2a2a;
    }

    .dot-plain {
      background: #888;
    }

    .question-block {
      margin-bottom: 48px;
    }

    .question-label {
      font-size: 11px;
      text-transform: uppercase;
      letter-spacing: 0.1em;
      color: #888;
      margin-bottom: 4px;
    }

    .question-text {
      font-size: 15px;
      font-weight: bold;
      margin-bottom: 18px;
      color: #111;
      border-left: 3px solid #1a1a1a;
      padding-left: 10px;
    }

    .comparison-grid {
      display: grid;
      grid-template-columns: 1fr 1fr;
      border: 1px solid #ddd;
    }

    .col-header {
      padding: 10px 14px;
      font-size: 11px;
      font-weight: bold;
      text-transform: uppercase;
      letter-spacing: 0.08em;
      border-bottom: 1px solid #ddd;
    }

    .col-header.kg {
      background: #1a1a1a;
      color: #fff;
      border-right: 1px solid #ddd;
    }

    .col-header.plain {
      background: #f0f0f0;
      color: #333;
    }

    .cell {
      padding: 14px 16px;
      vertical-align: top;
    }

    .cell.kg {
      border-right: 1px solid #ddd;
      background: #fafafa;
    }

    .cell.plain {
      background: #fff;
    }

    .cell-section-label {
      font-size: 10px;
      text-transform: uppercase;
      letter-spacing: 0.1em;
      color: #999;
      margin-bottom: 5px;
      font-family: 'Courier New', monospace;
    }

    .cell-content {
      font-size: 13.5px;
      color: #222;
    }

    .reasoning-body {
      overflow: hidden;
      transition: max-height 0.3s ease;
    }

    .reasoning-body.collapsed {
      display: -webkit-box;
      -webkit-line-clamp: 2;
      -webkit-box-orient: vertical;
      overflow: hidden;
    }

    .cell-content.collapsed {
      display: -webkit-box;
      -webkit-line-clamp: 2;
      -webkit-box-orient: vertical;
      overflow: hidden;
    }

    .show-toggle {
      display: inline-block;
      margin-top: 5px;
      font-size: 11px;
      color: #aaa;
      cursor: pointer;
      user-select: none;
      font-family: 'Courier New', monospace;
      letter-spacing: 0.04em;
    }

    .show-toggle:hover {
      color: #555;
    }

    .divider-row {
      grid-column: 1 / -1;
      height: 1px;
      background: #e0e0e0;
    }

    .notes-row {
      grid-column: 1 / -1;
      background: #fffdf4;
      border-top: 1px solid #e8e0c0;
      padding: 12px 16px;
    }

    .notes-label {
      font-size: 10px;
      text-transform: uppercase;
      letter-spacing: 0.1em;
      color: #b0902a;
      margin-bottom: 4px;
      font-family: 'Courier New', monospace;
    }

    .notes-content {
      font-size: 13px;
      color: #555;
      font-style: italic;
    }

    h1,
    h2,
    h3 {
      color: #333;
      margin-top: 0.8em;
      margin-bottom: 0.5em;
    }

    h1 {
      font-size: 2em;
    }

    h2 {
      font-size: 1.5em;
    }

    h3 {
      font-size: 1.2em;
    }

    code {
      background: #f4f4f4;
      padding: 2px 4px;
      border-radius: 3px;
      font-family: 'Courier New', monospace;
    }

    pre {
      background: #f4f4f4;
      padding: 15px;
      border-radius: 5px;
      overflow-x: auto;
      font-family: 'Courier New', monospace;
      line-height: 1.4;
    }

    blockquote {
      border-left: 4px solid #ddd;
      margin: 1em 0;
      padding-left: 20px;
      color: #ffffff;
      font-style: italic;
      background-color: #444;
    }

    table {
      border-collapse: collapse;
      width: 100%;
      margin: 1em 0;
    }

    th,
    td {
      border: 1px solid #ddd;
      padding: 8px 12px;
      text-align: left;
    }

    th {
      background-color: #f5f5f5;
      font-weight: bold;
    }

    ul,
    ol {
      margin: 1em 0;
      padding-left: 2em;
    }

    li {
      margin: 0.5em 0;
    }
  </style>
</head>

<body>

  <header>
    <h1>Model Response Comparison: Opus KG-mcp vs. Opus Plain</h1>
    <p>Domain: Neurodevelopmental Biology &nbsp;·&nbsp; Format: Reasoning + Direct Response &nbsp;·&nbsp; Evaluated: 3
      questions</p>
  </header>

  <div class="legend">
    <span><span class="legend-dot dot-kg"></span> Opus KG-mcp — knowledge-graph augmented</span>
    <span><span class="legend-dot dot-plain"></span> Opus Plain — baseline model</span>
  </div>

  <!-- QUESTION 1 -->
  <div class="question-block">
    <div class="question-label">Question 1</div>
    <div class="question-text">Considering that the medial eminence is exposed to vascularisation, which tanycyte
      subtypes would you expect to show the strongest increase in immune programs in aging?</div>
    <div class="comparison-grid">
      <div class="col-header kg">Opus KG-mcp</div>
      <div class="col-header plain">Opus Plain</div>

      <div class="cell kg">
        <div class="cell-section-label">Reasoning</div>
        <div class="cell-content">
          <div class="reasoning-body collapsed">
            <h3>Tanycyte subtype identity from the graph</h3>
            <p>Based on spatial mapping and transcription factor profiles, the 8 tanycyte clusters map to classical
              subtypes as follows:</p>
            <table>
              <thead>
                <tr>
                  <th>Cluster</th>
                  <th>Supertype</th>
                  <th>Primary region</th>
                  <th>Classical identity</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td>5243</td>
                  <td>NN_1</td>
                  <td>Choroid plexus / SFO</td>
                  <td>CVO-associated</td>
                </tr>
                <tr>
                  <td>5244</td>
                  <td>NN_1</td>
                  <td>AVPV / OVLT</td>
                  <td>CVO-associated</td>
                </tr>
                <tr>
                  <td>5245</td>
                  <td>NN_2</td>
                  <td>PVi (88%)</td>
                  <td><strong>α1-tanycyte</strong></td>
                </tr>
                <tr>
                  <td>5246</td>
                  <td>NN_2</td>
                  <td>PVi + ARH</td>
                  <td><strong>α2-tanycyte</strong></td>
                </tr>
                <tr>
                  <td>5247</td>
                  <td>NN_2</td>
                  <td>ARH (60%) + PVp</td>
                  <td><strong>β1-tanycyte</strong></td>
                </tr>
                <tr>
                  <td>5248</td>
                  <td>NN_2</td>
                  <td>PVp + V3</td>
                  <td>α2-posterior</td>
                </tr>
                <tr>
                  <td>5249</td>
                  <td>NN_2</td>
                  <td>ARH (76%) + V3</td>
                  <td><strong>β1-tanycyte</strong></td>
                </tr>
                <tr>
                  <td><strong>5250</strong></td>
                  <td><strong>NN_3</strong></td>
                  <td><strong>ME (46%)</strong> + ARH</td>
                  <td><strong>β2-tanycyte</strong></td>
                </tr>
              </tbody>
            </table>
            <h3>Ranked predictions</h3>
            <p><strong>1. β2-tanycytes (cluster 5250 / Tanycyte NN_3) - strongest effect</strong></p>
            <ul>
              <li><strong>Only tanycyte cluster with direct ME mapping</strong> (fraction = 0.46) - no other tanycyte
                cluster shows any ME signal.</li>
              <li>β2-tanycytes line the ventral floor of the 3rd ventricle and extend processes into the ME external
                zone, where they directly contact <strong>fenestrated capillaries</strong> of the
                hypothalamic-hypophyseal portal system. These capillaries lack a blood-brain barrier.</li>
              <li>This makes β2-tanycytes the primary cellular interface between peripheral blood and the CNS at the
                ME. During aging, rising levels of circulating pro-inflammatory cytokines (IL-6, TNF-α, IL-1β -
                &quot;inflammaging&quot;) would directly stimulate these cells.</li>
              <li>The marker <strong>Ecrg4</strong> (augurin) is notable: it encodes a secreted peptide that is cleaved
                under inflammatory conditions and has been shown to activate innate immune pathways. Its expression in
                β2-tanycytes supports a role as an immune sentinel.</li>
              <li>TF <strong>Fosb</strong> (an immediate-early gene/AP-1 component) suggests these cells are
                particularly responsive to extracellular stimuli, including inflammatory signaling cascades.</li>
            </ul>
            <p><strong>2. β1-tanycytes (clusters 5247, 5249 / Tanycyte NN_2 subset) - moderate effect</strong></p>
            <ul>
              <li>Map predominantly to the <strong>arcuate nucleus</strong> (ARH), which sits immediately adjacent to
                the ME and receives vascular leakage from ME fenestrated capillaries.</li>
              <li>β1 processes extend laterally along the ME border, giving them partial exposure to blood-borne
                signals.</li>
              <li>They would receive paracrine inflammatory signals from β2-tanycytes and experience indirect BBB
                compromise.</li>
              <li>TFs <strong>Tbx3</strong> (5247) and <strong>Six6</strong> (5249) suggest distinct functional
                identities but shared vascular adjacency.</li>
            </ul>
            <p><strong>3. α2-tanycytes (cluster 5246) - lower but non-negligible</strong></p>
            <ul>
              <li>Map to PVi + ARH, more dorsal than β-tanycytes.</li>
              <li>Notably, <strong>Dock8</strong> is a cell-type marker - this is a guanine nucleotide exchange factor
                critically involved in immune cell migration and dendritic cell function. Its expression as a defining
                marker suggests these cells have some baseline immune-interface capacity.</li>
              <li>However, being more distant from fenestrated capillaries, the effect would be weaker.</li>
            </ul>
            <p><strong>4. α1-tanycytes and CVO-associated tanycytes - least effect at ME specifically</strong></p>
            <ul>
              <li>β1 (5245) maps to dorsal PVi, far from ME vasculature.</li>
              <li>NN_1 clusters (5243, 5244) are at other CVOs (SFO, OVLT, choroid plexus) - they would show immune
                activation from vascular exposure at <em>their respective locations</em>, but not from ME-specific
                vascularization.</li>
            </ul>
            <h3>Mechanistic rationale</h3>
            <p>The key biological principle is <strong>gradient of vascular exposure</strong>: the ME has fenestrated
              capillaries without BBB -> β2-tanycytes (floor of 3rd ventricle, processes in ME parenchyma) are
              maximally exposed -> β1-tanycytes (lateral ME/ventral ARH) have partial exposure -> α-tanycytes (more
              dorsal) are progressively shielded. During aging, peripheral inflammatory load increases
              (&quot;inflammaging&quot;), and the cells with the most direct vascular contact will show the strongest
              transcriptional upregulation of innate immune programs (MHC-I, interferon-stimulated genes, complement,
              NF-╬║B targets).</p>
            <h3>Remaining uncertainty</h3>
            <ul>
              <li>The graph database captures steady-state adult markers, not aging dynamics - the prediction is based
                on anatomical position and vascular exposure logic rather than direct aging transcriptomic data.</li>
              <li>Whether immune program upregulation is cell-autonomous (direct cytokine sensing) or paracrine (via
                ME-resident microglia/macrophages signaling to tanycytes) cannot be distinguished from this data alone.
              </li>
            </ul>
          </div>
          <span class="show-toggle">show more</span>
        </div>
      </div>
      <div class="cell plain">
        <div class="cell-section-label">Reasoning</div>
        <div class="cell-content">
          <div class="reasoning-body collapsed"> Here&#39;s the reasoning:
            <h3>Anatomical logic</h3>
            <p>Tanycytes are arrayed along a dorsoventral gradient on the walls and floor of the third ventricle, and
              their subtypes differ critically in what they contact:</p>
            <table>
              <thead>
                <tr>
                  <th>Subtype</th>
                  <th>Position</th>
                  <th>Vascular contact</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td>α1</td>
                  <td>Dorsal (VMH region)</td>
                  <td>Standard BBB vasculature</td>
                </tr>
                <tr>
                  <td>α2</td>
                  <td>Intermediate (arcuate)</td>
                  <td>Standard BBB vasculature</td>
                </tr>
                <tr>
                  <td><strong>β1</strong></td>
                  <td>Lateral ME</td>
                  <td>Approaching fenestrated capillaries</td>
                </tr>
                <tr>
                  <td><strong>β2</strong></td>
                  <td>Floor / ventral ME</td>
                  <td><strong>Processes terminate directly on fenestrated portal capillaries</strong></td>
                </tr>
              </tbody>
            </table>
            <p>The median eminence is a <strong>circumventricular organ</strong> — its capillary plexus is fenestrated
              and lacks a conventional blood-brain barrier. This means blood-borne cytokines, DAMPs, and other
              inflammatory mediators have direct access.</p>
            <h3>Why β2 tanycytes specifically</h3>
            <p><strong>β2 tanycytes</strong> are the subtype whose end-feet directly abut the fenestrated perivascular
              space of the ME. During aging, systemic &quot;inflammaging&quot; elevates circulating pro-inflammatory
              factors (TNFα, IL-6, IL-1β, etc.). Because β2 tanycytes are the first CNS-resident cells to encounter
              these signals without BBB filtering, they would be expected to show the <strong>strongest transcriptional
                activation of innate immune and interferon-response programs</strong> — including upregulation of genes
              in the MHC-I/II pathway, complement cascade, and NF-κB signaling.</p>
            <p><strong>β1 tanycytes</strong> occupy the lateral ME and have partial exposure to this milieu, so they
              represent a graded, somewhat weaker response.</p>
            <p><strong>α1/α2 tanycytes</strong>, by contrast, sit behind a conventional BBB and are largely shielded
              from peripheral inflammatory signals, so their immune program activation during aging would be
              comparatively modest.</p>
            <h3>Summary</h3>
            <blockquote>
              <p>Given the fenestrated vasculature of the median eminence, <strong>β2 tanycytes</strong> — and to a
                lesser extent <strong>β1 tanycytes</strong> — are the subtypes most directly exposed to age-related
                increases in circulating inflammatory mediators. They would therefore be predicted to show the strongest
                upregulation of immune and inflammatory transcriptional programs with aging.</p>
            </blockquote>
          </div>
          <span class="show-toggle">show more</span>
        </div>
      </div>

      <div class="divider-row"></div>

      <div class="cell kg">
        <div class="cell-section-label">Answer</div>
        <div class="cell-content"><b>β2-tanycytes</b> (Tanycyte NN_3) and <b>β1-tanycytes</b> would show the strongest
          increase in immune programs during aging.</div>
      </div>
      <div class="cell plain">
        <div class="cell-section-label">Answer</div>
        <div class="cell-content">
          <p>The answer centers on <strong>β2 tanycytes</strong>, with <strong>β1 tanycytes</strong> as a secondary
            candidate.</p>
        </div>
      </div>

      <div class="notes-row">
        <div class="notes-label">Observations</div>
        <div class="notes-content">Bla bla bla</div>
      </div>
    </div>
  </div>

  <!-- QUESTION 2 -->
  <div class="question-block">
    <div class="question-label">Question 2</div>
    <div class="question-text">I want to target genetically somatostatin interneurons of cortex somatosensory layer 4,
      specifically, without targeting any other population among the Sst positive populations. Which gene should I
      target?
    </div>
    <div class="comparison-grid">
      <div class="col-header kg">Opus KG-mcp</div>
      <div class="col-header plain">Opus Plain</div>

      <div class="cell kg">
        <div class="cell-section-label">Reasoning</div>
        <div class="cell-content">
          <div class="reasoning-body collapsed">
            <p><strong>Step 1 - Identify the target population:</strong>
              Among all 96 Sst clusters in the database, I identified which ones are spatially enriched in somatosensory
              cortex layer 4 (SSs4). The top hit is <strong>cluster 799 (Sst Gaba_9)</strong> with 14% of its cells
              mapped to SSs4 - the highest of any Sst cluster by a wide margin (next: cluster 800 at 7%, cluster 801
              at 5%).</p>
            <p><strong>Step 2 - Find unique markers:</strong>
              Cluster 799 has three cell-type markers: <strong>Dysf</strong>, Pdyn, and Prdm1. I tested each for
              uniqueness across all Sst populations:</p>
            <table>
              <thead>
                <tr>
                  <th>Marker</th>
                  <th># other Sst clusters sharing it</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td><strong>Dysf</strong></td>
                  <td><strong>0</strong></td>
                </tr>
                <tr>
                  <td>Pdyn</td>
                  <td>25</td>
                </tr>
                <tr>
                  <td>Prdm1</td>
                  <td>15</td>
                </tr>
              </tbody>
            </table>
            <p><strong>Dysf is a ct_marker for exactly ONE cluster in the entire database</strong> - cluster 799. No
              other Sst cluster, and in fact no other cluster of any type, carries Dysf as a marker.</p>
            <p><strong>Step 3 - Proposed targeting strategy:</strong>
              An intersectional genetic approach using <strong>Sst-Cre × Dysf-Flp</strong> (or equivalent
              dual-recombinase system) would:</p>
            <ul>
              <li>Restrict labeling to Sst+ cells (eliminating all non-interneuron expression)</li>
              <li>Within Sst+, restrict to only cluster 799 (the most L4-somatosensory-enriched Sst type)</li>
              <li>Exclude all other 95 Sst populations</li>
            </ul>
            <h3>Caveats</h3>
            <ul>
              <li>Cluster 799 is enriched in SS L4 (14%) but not exclusive to it - it also appears in VISp layer 4
                (6%) and MOp layer 5 (4%). A viral injection restricted to somatosensory cortex would solve this spatial
                specificity.</li>
              <li>If you need broader coverage of <em>all</em> Sst cells in SS L4 (not just the most enriched cluster),
                consider <strong>Prdm1</strong>, which marks the entire Sst Gaba_9 supertype (clusters 798-801,
                collectively ~27% in SSs4), but at the cost of also marking 15 other Sst clusters elsewhere.</li>
              <li><strong>Zfp618</strong> is also a transcription factor unique to cluster 799 among Sst populations and
                could serve as an alternative.</li>
            </ul>
            <p><strong>Bottom line:</strong> For maximum specificity to Sst+ layer 4 somatosensory interneurons without
              off-targeting other Sst populations, target <strong>Dysf</strong>.</p>
            <b>My follow up:</b> <em>Somebody suggests: "Hpse, since Hpse is the only marker that is specific to that
              population and not others”. Is he right or wrong?</em>
            <br>Opus: <br>
            I already checked Hpse earlier. Let me pull up the data explicitly to evaluate the claim.
            <p><strong>He&#39;s wrong.</strong> Hpse is not specific to the SS L4 Sst population. It is a ct_marker
              shared by <strong>7 different Sst clusters</strong> across 5 different supertypes:</p>
            <table>
              <thead>
                <tr>
                  <th>Cluster</th>
                  <th>Supertype</th>
                  <th>In SSs4?</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td>768</td>
                  <td>Sst Gaba_3</td>
                  <td>No</td>
                </tr>
                <tr>
                  <td>792</td>
                  <td>Sst Gaba_7</td>
                  <td>5%</td>
                </tr>
                <tr>
                  <td>793</td>
                  <td>Sst Gaba_7</td>
                  <td>4%</td>
                </tr>
                <tr>
                  <td>794</td>
                  <td>Sst Gaba_7</td>
                  <td>No</td>
                </tr>
                <tr>
                  <td><strong>800</strong></td>
                  <td><strong>Sst Gaba_9</strong></td>
                  <td><strong>7%</strong></td>
                </tr>
                <tr>
                  <td>816</td>
                  <td>Sst Gaba_15</td>
                  <td>No</td>
                </tr>
                <tr>
                  <td>828</td>
                  <td>Sst Gaba_19</td>
                  <td>No</td>
                </tr>
              </tbody>
            </table>
            <p>Targeting Hpse within an Sst-Cre strategy would hit at least 7 clusters spanning 5 supertypes - most of
              which have nothing to do with somatosensory layer 4. This directly violates the requirement of &quot;not
              targeting any other Sst population.&quot;</p>
            <p><strong>Dysf</strong> remains the correct answer: it marks exactly 1 cluster (799) out of 96 Sst
              clusters, and that cluster is the most SSs4-enriched Sst type in the database.</p>
          </div>
          <span class="show-toggle">show more</span>
        </div>
      </div>
      <div class="cell plain">
        <div class="cell-section-label">Reasoning</div>
        <div class="cell-content">
          <div class="reasoning-body collapsed">
            <p>In the Allen Institute&#39;s transcriptomic taxonomy of adult mouse cortex (Tasic et al., 2018), Sst
              interneurons are split into numerous transcriptomic subtypes. Among these, the <strong>Sst Hpse</strong>
              cluster(s) (e.g., <em>Sst Hpse Cbln4</em>, <em>Sst Hpse Sema3c</em>) are specifically enriched in
              <strong>layer 4 of primary sensory cortices</strong>, including somatosensory barrel cortex (SSp).
            </p>
            <p>Why Hpse works as a discriminating marker:</p>
            <ol>
              <li>
                <p><strong>Layer specificity</strong> - Hpse expression within Sst+ neurons is heavily biased toward
                  L4, where these interneurons provide feedforward inhibition onto excitatory stellate/pyramidal cells
                  receiving thalamocortical input.</p>
              </li>
              <li>
                <p><strong>Exclusion of other Sst populations</strong> - Other major Sst subtypes (e.g., Sst Chodl
                  long-range projecting neurons, Sst Calb2 Martinotti-like cells in L2/3-L5, Sst Chrna2, Sst Myh8,
                  etc.) do <strong>not</strong> co-express Hpse at significant levels, making it a clean discriminator
                  within the Sst lineage.</p>
              </li>
              <li>
                <p><strong>Region enrichment</strong> - Hpse-expressing Sst neurons are enriched in granular sensory
                  cortices (which have a prominent L4), further narrowing expression to somatosensory, visual, and
                  auditory cortex - regions with prominent thalamocortical L4 input.</p>
              </li>
            </ol>
            <h2>Practical Targeting Strategy</h2>
            <p>Use an <strong>intersectional genetic approach</strong>:</p>
            <table>
              <thead>
                <tr>
                  <th>Component</th>
                  <th>Purpose</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td><strong>Sst-Cre</strong> driver line</td>
                  <td>Restricts to all Sst+ interneurons</td>
                </tr>
                <tr>
                  <td><strong>Hpse-FlpO</strong> driver (or Hpse enhancer-driven AAV)</td>
                  <td>Restricts to Hpse+ cells</td>
                </tr>
                <tr>
                  <td><strong>Cre- and Flp-dependent effector</strong> (e.g., dual-recombinase AAV)</td>
                  <td>Only activates at the intersection</td>
                </tr>
              </tbody>
            </table>
            <p>Injecting into somatosensory cortex adds a third layer of spatial restriction, giving you highly specific
              access to L4 Sst interneurons of SSp.</p>
            <h2>Caveats</h2>
            <ul>
              <li>If absolute exclusivity is required, confirm with single-cell RNA-seq data (e.g., Allen Brain Cell
                Atlas) that Hpse is not expressed in any off-target Sst subtype in your specific region of interest.
              </li>
              <li>A small number of Hpse+ Sst neurons may exist in L4 of other sensory cortices (V1, A1), so stereotaxic
                injection coordinates provide the final spatial restriction to somatosensory cortex specifically.</li>
            </ul>
          </div>
          <span class="show-toggle">show more</span>
        </div>
      </div>

      <div class="divider-row"></div>

      <div class="cell kg">
        <div class="cell-section-label">Answer</div>
        <div class="cell-content">Answer: <b>Dysf</b> (Dysferlin)</div>
      </div>
      <div class="cell plain">
        <div class="cell-section-label">Answer</div>
        <div class="cell-content"><b>Hpse</b> (heparanase) is the gene you should target in an intersectional strategy
          with Sst.</div>
      </div>

      <div class="notes-row">
        <div class="notes-label">Observations</div>
        <div class="notes-content">Different response ! Note that Opus-KG even if prompted with a
          follow-up regarding Hpse, still held its ground. Also plain Opus said to check whether Hpse is expressed in
          any off-target Sst subtype in your specific region, which was exactly what Opus-KG did and why it discarded
          Hpse. -- (from both reasoning lines)</div>
      </div>
    </div>
  </div>

  <!-- QUESTION 3 -->
  <div class="question-block">
    <div class="question-label">Question 3</div>
    <div class="question-text">How many electrophysiologically distinct populations (by populations I mean, typically
      exhibiting different neuropeptides) would light up if I used an enhancer targeting Lamp5?
    </div>
    <div class="comparison-grid">
      <div class="col-header kg">Opus KG-mcp</div>
      <div class="col-header plain">Opus Plain</div>

      <div class="cell kg">
        <div class="cell-section-label">Reasoning</div>
        <div class="cell-content">
          <div class="reasoning-body collapsed">These 26 clusters exhibit <strong>13 unique
              neuropeptide signatures</strong>, which define the electrophysiologically distinct populations:</p>
            <table>
              <thead>
                <tr>
                  <th>#</th>
                  <th>Neuropeptide signature</th>
                  <th>Clusters</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td>1</td>
                  <td>Cort + Npy + Cck + Pnoc</td>
                  <td>706, 709, 710, 724, 725, 726, 731</td>
                </tr>
                <tr>
                  <td>2</td>
                  <td>Cck + Pnoc</td>
                  <td>711, 712, 720, 722, 723</td>
                </tr>
                <tr>
                  <td>3</td>
                  <td>Npy + Cck + Pnoc</td>
                  <td>715, 721, 730</td>
                </tr>
                <tr>
                  <td>4</td>
                  <td>Npy + Pnoc</td>
                  <td>707, 718</td>
                </tr>
                <tr>
                  <td>5</td>
                  <td>Cort + Npy + Pnoc</td>
                  <td>708</td>
                </tr>
                <tr>
                  <td>6</td>
                  <td>Cort + Cck + Pnoc</td>
                  <td>729</td>
                </tr>
                <tr>
                  <td>7</td>
                  <td>Pnoc only</td>
                  <td>713</td>
                </tr>
                <tr>
                  <td>8</td>
                  <td>Npy + Penk + Pnoc + Crh + Tac2</td>
                  <td>714</td>
                </tr>
                <tr>
                  <td>9</td>
                  <td>Crh + Npy + Pnoc</td>
                  <td>717</td>
                </tr>
                <tr>
                  <td>10</td>
                  <td>Npy + Tac2</td>
                  <td>716</td>
                </tr>
                <tr>
                  <td>11</td>
                  <td>Npy + Tac2 + Cck</td>
                  <td>719</td>
                </tr>
                <tr>
                  <td>12</td>
                  <td>Sst + Pnoc + Cort + Tac1</td>
                  <td>727</td>
                </tr>
                <tr>
                  <td>13</td>
                  <td>Pnoc + Cartpt + Cort + Tac1 + Cck</td>
                  <td>728</td>
                </tr>
              </tbody>
            </table>
            <p>Key biological patterns:</p>
            <ul>
              <li><strong>Pnoc (prepronociceptin)</strong> is nearly universal (24/26 clusters), serving as a Lamp5
                lineage signature.</li>
              <li><strong>Cck</strong> and <strong>Npy</strong> are the next most common, splitting the population into
                major subgroups.</li>
              <li><strong>Cort</strong> marks a distinct subset (11 clusters), predominantly in the Lamp5 Lhx6-derived
                (MGE-origin) populations.</li>
              <li>Rare neuropeptides (<strong>Tac1, Tac2, Crh, Penk, Cartpt, Sst</strong>) define the most specialized
                populations, mostly singleton clusters.</li>
              <li>The Lamp5 Lhx6 subclass (MGE-derived) shows richer neuropeptide diversity (Sst, Tac1, Cartpt) compared
                to the CGE-derived Lamp5 Gaba subclass, consistent with their distinct developmental origins.</li>
            </ul>
            <h2>Doubts</h2>
            <ul>
              <li>All neuropeptide markers have <code>avg_log2 = 1.0</code>, so I cannot distinguish dominant vs.
                low-level co-expression. In practice, some neuropeptides may be expressed at sub-functional levels,
                which would reduce the number of truly <em>functionally</em> distinct populations.</li>
              <li>An enhancer&#39;s actual labeling efficiency may not capture all 26 clusters equally - some may
                express Lamp5 at levels below the enhancer&#39;s activation threshold, potentially labeling fewer
                populations in practice.</li>
              <li>The electrophysiological distinctness implied by neuropeptide differences is an approximation; cells
                with identical neuropeptide signatures but different ion channel profiles could still differ
                electrophysiologically.</li>
            </ul>
            <b>My follow up:</b> <em> Ok, just to be clear, what are this 2 subclasses you found and talked about?</em>
            <p>The two Lamp5 subclasses are:</p>
            <ol>
              <li><strong>Lamp5 Gaba</strong> - CGE-derived (caudal ganglionic eminence), 18 clusters</li>
              <li><strong>Lamp5 Lhx6 Gaba</strong> - MGE-derived (medial ganglionic eminence), 8 clusters</li>
            </ol>
            <p>The key distinction is <strong>Lhx6</strong>: it&#39;s a transcription factor that marks MGE-derived
              interneurons. So while both subclasses express Lamp5, they originate from different embryonic progenitor
              zones, giving the Lhx6+ group a distinct molecular and electrophysiological identity (e.g., the unique
              Sst, Tac1, Cartpt neuropeptide markers).</p>
          </div>
          <span class="show-toggle">show more</span>
        </div>
      </div>
      <div class="cell plain">
        <div class="cell-section-label">Reasoning</div>
        <div class="cell-content">
          <div class="reasoning-body collapsed">
            <p>... distinguishable by their neuropeptide profiles: <br><br></p>
            <table>
              <thead>
                <tr>
                  <th>#</th>
                  <th>Neuropeptide Marker</th>
                  <th>Cell Type</th>
                  <th>Electrophysiological Signature</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td>1</td>
                  <td><strong>NPY</strong></td>
                  <td>Neurogliaform cells (Lamp5/Ndnf)</td>
                  <td>Late-spiking, dense local inhibition</td>
                </tr>
                <tr>
                  <td>2</td>
                  <td><strong>SST</strong></td>
                  <td>Lamp5/Lhx6 (MGE-derived)</td>
                  <td>Chandelier-like, fast-spiking features</td>
                </tr>
                <tr>
                  <td>3</td>
                  <td><strong>VIP</strong></td>
                  <td>Lamp5/Pax6 (single-bouquet-like)</td>
                  <td>Irregular/adapting spiking</td>
                </tr>
                <tr>
                  <td>4</td>
                  <td><strong>NOS1 (nNOS)</strong></td>
                  <td>Long-range projecting Lamp5 cells</td>
                  <td>Burst-spiking, long-range GABAergic projection</td>
                </tr>
              </tbody>
            </table>
            <h3>Key reasoning:</h3>
            <ul>
              <li><strong>Lamp5</strong> marks a subclass of CGE-derived (and some MGE-derived) GABAergic interneurons
              </li>
              <li>The <strong>Lamp5/Lhx6</strong> population is notable because it is MGE-derived (unlike most Lamp5
                cells) and co-expresses <strong>SST</strong> - electrophysiologically it resembles chandelier cells
              </li>
              <li>The <strong>neurogliaform</strong> (Lamp5/Ndnf/<strong>NPY+</strong>) population is the canonical
                Lamp5 type with a distinctive late-spiking phenotype and volume transmission of GABA</li>
              <li><strong>nNOS+</strong> Lamp5 cells are a distinct long-range projecting population with burst-spiking
                properties</li>
              <li>Some subtypes co-express <strong>VIP</strong> or <strong>CCK</strong>, but VIP marks the more
                electrophysiologically distinct group among these</li>
            </ul>
            <p>So the short answer: <strong>4</strong> electrophysiologically distinct neuropeptide-defined populations
              would light up with a Lamp5 enhancer.</p>
          </div>
          <span class="show-toggle">show more</span>
        </div>
      </div>

      <div class="divider-row"></div>

      <div class="cell kg">
        <div class="cell-section-label">Answer</div>
        <div class="cell-content">
          <p><strong>13 distinct neuropeptide-defined populations</strong> would light up with a Lamp5 enhancer. A Lamp5
            enhancer would label <strong>26 clusters</strong> spanning <strong>2 subclasses</strong> (Lamp5
            Gaba, Lamp5 Lhx6 Gaba) and <strong>5 supertypes</strong>.
        </div>
      </div>
      <div class="cell plain">
        <div class="cell-section-label">Answer</div>
        <div class="cell-content">Based on the transcriptomic taxonomy of the adult mouse brain (Allen Brain Cell Atlas;
          Tasic et al. 2018; Gouwens et al. 2020; Yao et al. 2021, 2023), an enhancer targeting <b>Lamp5</b> would label
          <b>~4 major electrophysiologically distinct populations</b>, distinguishable by their neuropeptide profiles:
        </div>
      </div>

      <div class="notes-row">
        <div class="notes-label">Observations</div>
        <div class="notes-content">Bla bla</div>
      </div>
    </div>
  </div>

  <!-- QUESTION 4 -->
  <div class="question-block">
    <div class="question-label">Question 4</div>
    <div class="question-text">Consider the two parvalbuminergic subtypes Pvalb basket and Pvalb chandelier in the
      primary somatosensory area S1 brain region. Do we expect one of the two cell types to be more frequently positive
      to Pvalb or are they expected to have similar Pvalb positivity proportions?
    </div>
    <div class="comparison-grid">
      <div class="col-header kg">Opus KG-mcp</div>
      <div class="col-header plain">Opus Plain</div>

      <div class="cell kg">
        <div class="cell-section-label">Reasoning</div>
        <div class="cell-content">
          <div class="reasoning-body collapsed">
            <h3>Evidence from the graph</h3>
            <ul>
              <li>In the Allen Brain Cell Atlas taxonomy encoded here, there are 2 chandelier clusters (732, 733) under
                subclass <code>Pvalb chandelier Gaba</code> and 22 basket-type clusters (734-755) under subclass
                <code>Pvalb Gaba</code>.
              </li>
              <li><strong>Pvalb is listed as a cluster-level differentiating marker (<code>Has_ct_marker</code>) for 1
                  basket cluster (cluster:740) but for zero chandelier clusters.</strong> This signals that Pvalb
                expression is high enough in some basket clusters to serve as a distinguishing marker at fine
                resolution, but never reaches that status in chandelier cells.</li>
              <li>The chandelier clusters instead carry distinct markers like <strong>Pthlh</strong>,
                <strong>Krt12</strong>, and <strong>Sfta3-ps</strong> - known chandelier-specific genes - while
                Pvalb itself is not among them.
              </li>
            </ul>
            <h3>Biological reasoning</h3>
            <ol>
              <li>
                <p><strong>Expression levels</strong>: Single-cell RNA-seq studies (including the Allen ABC Atlas
                  underlying this graph) consistently show that Pvalb basket cells express <em>Pvalb</em> at
                  <strong>higher average levels</strong> than chandelier cells. Chandelier cells have more variable,
                  lower-magnitude Pvalb transcription.
                </p>
              </li>
              <li>
                <p><strong>Immunohistochemical detection</strong>: Because chandelier cells express Pvalb at lower
                  levels, a substantial fraction fall <strong>below detection thresholds</strong> in standard anti-Pvalb
                  immunostaining. Studies in mouse somatosensory cortex have shown that many morphologically confirmed
                  chandelier cells are Pvalb-immunonegative, while basket cells are more uniformly Pvalb-positive.</p>
              </li>
              <li>
                <p><strong>Developmental and functional context</strong>: Chandelier cells (axo-axonic cells) and basket
                  cells arise from the medial ganglionic eminence but diverge in maturation. Basket cells upregulate
                  Pvalb earlier and maintain higher steady-state levels, consistent with their higher firing rates and
                  greater metabolic demand for calcium buffering. Chandelier cells, while still Pvalb-lineage, rely on
                  additional markers (Pthlh, Vipr2) for their identity and have a more heterogeneous Pvalb expression
                  profile.</p>
              </li>
            </ol>
            <h3>Conclusion</h3>
            <p>In S1 (primary somatosensory cortex), <strong>Pvalb basket cells should show a higher proportion of
                Pvalb-positive cells</strong> compared to chandelier cells. Both types belong to the Pvalb family, but
              chandelier cells express the gene at lower and more variable levels, leading to a lower &quot;positivity
              rate&quot; - particularly when assessed by protein-level methods like immunohistochemistry.</p>

          </div>
          <span class="show-toggle">show more</span>
        </div>
      </div>
      <div class="cell plain">
        <div class="cell-section-label">Reasoning</div>
        <div class="cell-content">
          <div class="reasoning-body collapsed">
            <p>Although both subtypes are classified under the Pvalb transcriptomic class, they differ meaningfully in
              their parvalbumin expression levels:</p>
            <p><strong>Pvalb basket cells:</strong></p>
            <ul>
              <li>Express Pvalb at consistently high levels - it is one of their most robust and defining markers.
              </li>
              <li>Virtually all basket cells are detectably Pvalb-positive regardless of assay (scRNA-seq, FISH, IHC).
              </li>
            </ul>
            <p><strong>Pvalb chandelier cells:</strong></p>
            <ul>
              <li>Express Pvalb at <strong>lower and more variable</strong> levels compared to basket cells.</li>
              <li>Single-cell transcriptomic studies (including Allen Brain Cell Atlas data) consistently show that
                chandelier cells sit at the lower end of the Pvalb expression distribution within the broader Pvalb
                class.</li>
              <li>A non-trivial fraction of chandelier cells can fall below detection thresholds, particularly in less
                sensitive assays, reducing their apparent Pvalb-positivity rate.</li>
            </ul>
            <h3>Why the difference?</h3>
            <ol>
              <li>
                <p><strong>Distinct transcriptomic identity.</strong> Chandelier cells occupy a separate transcriptomic
                  branch from basket cells. While both derive from the medial ganglionic eminence and share core
                  PV-interneuron features, chandelier cells have a divergent gene-regulatory program that results in
                  lower baseline Pvalb transcription.</p>
              </li>
              <li>
                <p><strong>Functional correlate.</strong> Basket cells are the canonical fast-spiking perisomatic
                  inhibitors with very high metabolic demands, and Pvalb (a calcium buffer) is tightly coupled to that
                  physiology. Chandelier cells, which target the axon initial segment, have a partially different
                  electrophysiological and metabolic profile, consistent with somewhat lower calcium-buffering
                  requirements.</p>
              </li>
              <li>
                <p><strong>Empirical evidence.</strong> Patch-seq and MERFISH datasets from mouse cortex (including S1)
                  show that Pvalb transcript counts are systematically lower in chandelier-mapped clusters compared to
                  basket-mapped clusters.</p>
              </li>
            </ol>
            <h3>Summary</h3>
            <table>
              <thead>
                <tr>
                  <th>Feature</th>
                  <th>Pvalb Basket</th>
                  <th>Pvalb Chandelier</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td>Pvalb expression level</td>
                  <td>High, consistent</td>
                  <td>Lower, variable</td>
                </tr>
                <tr>
                  <td>Expected Pvalb positivity</td>
                  <td>~Near 100%</td>
                  <td>Appreciably lower</td>
                </tr>
                <tr>
                  <td>Relative abundance in S1</td>
                  <td>More common</td>
                  <td>Rare</td>
                </tr>
              </tbody>
            </table>
            <p><strong>Bottom line:</strong> We expect Pvalb basket cells to show a meaningfully higher Pvalb-positivity
              proportion than chandelier cells in S1, driven by intrinsic differences in transcriptional regulation of
              the <em>Pvalb</em> gene between these two subtypes.</p>

          </div>
          <span class="show-toggle">show more</span>
        </div>
      </div>

      <div class="divider-row"></div>

      <div class="cell kg">
        <div class="cell-section-label">Answer</div>
        <div class="cell-content">Pvalb basket cells are expected to have higher Pvalb positivity proportions than Pvalb
          chandelier cells.
        </div>
      </div>
      <div class="cell plain">
        <div class="cell-section-label">Answer</div>
        <div class="cell-content">Pvalb basket cells are expected to have a higher Pvalb-positivity proportion than
          Pvalb chandelier cells.
        </div>
      </div>

      <div class="notes-row">
        <div class="notes-label">Observations</div>
        <div class="notes-content">Bla bla</div>
      </div>
    </div>
  </div>


  <!-- QUESTION 5 -->
  <div class="question-block">
    <div class="question-label">Question 5</div>
    <div class="question-text">Which neuropeptide is expressed by cortex cells that would light up if I were to
      genetically target the striatal cholinergic neurons?</div>
    <div class="comparison-grid">
      <div class="col-header kg">Opus KG-mcp</div>
      <div class="col-header plain">Opus Plain</div>

      <div class="cell kg">
        <div class="cell-section-label">Reasoning</div>
        <div class="cell-content">
          <div class="reasoning-body collapsed">
            <p>Now I have a clear picture. Let me synthesize the reasoning.</p>
            <h3>1. Striatal cholinergic neurons and their genetic targeting</h3>
            <p>The striatal cholinergic interneurons (clusters 923-932, &quot;PAL-STR Gaba-Chol&quot;) are canonically
              targeted using a <strong>Chat-Cre</strong> driver line. All 6 clusters express Chat as a neurotransmitter
              marker, along with Slc18a3 (VAChT) and Slc5a7 (high-affinity choline transporter).</p>
            <h3>2. Which cortical cells express the cholinergic machinery?</h3>
            <p>A Chat-Cre line drives recombination in <strong>all Chat-expressing cells</strong>, not just striatal
              ones. In the cortex, the cells that express cholinergic genes are the <strong>Sst Chodl
                interneurons</strong> - the long-range projecting GABAergic neurons. The database confirms this:
              cluster 859 (Sst Chodl Gaba_4, observed in Isocortex) carries <strong>Slc5a7</strong> as a cell-type
              marker, directly linking it to the cholinergic molecular program. These neurons are well-documented in the
              literature to express Chat at low levels and are reliably labeled in Chat-Cre mice.</p>
            <h3>3. Neuropeptides of cortical Sst Chodl neurons</h3>
            <p>The two cortical Sst Chodl clusters (858, 859) express:</p>
            <table>
              <thead>
                <tr>
                  <th>Neuropeptide</th>
                  <th>Cluster 858</th>
                  <th>Cluster 859</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td><strong>Sst</strong></td>
                  <td>yes</td>
                  <td>yes</td>
                </tr>
                <tr>
                  <td><strong>Npy</strong></td>
                  <td>yes</td>
                  <td>yes</td>
                </tr>
                <tr>
                  <td><strong>Cort</strong> (cortistatin)</td>
                  <td>yes</td>
                  <td>yes</td>
                </tr>
                <tr>
                  <td>Pdyn</td>
                  <td>yes</td>
                  <td>-</td>
                </tr>
                <tr>
                  <td>Penk</td>
                  <td>-</td>
                  <td>yes</td>
                </tr>
              </tbody>
            </table>
            <p><strong>Sst</strong> and <strong>Npy</strong> are the most consistent neuropeptide markers across the
              entire Sst Chodl family (Sst in 18/18 clusters, Npy in 16/18). <strong>Cort</strong> (cortistatin,
              structurally related to somatostatin) is shared by both cortical clusters and adds specificity.</p>
            <h3>Bottom line</h3>
            <p>If you use a Chat-Cre line to target striatal cholinergic interneurons, the cortical cells that
              &quot;light up&quot; as off-target labeling are the <strong>Sst/Chodl long-range projecting
                interneurons</strong>, and their defining neuropeptide is <strong>somatostatin (Sst)</strong>, with
              <strong>Npy</strong> and <strong>cortistatin (Cort)</strong> as co-expressed neuropeptides.
            </p>

          </div>
          <span class="show-toggle">show more</span>
        </div>
      </div>
      <div class="cell plain">
        <div class="cell-section-label">Reasoning</div>
        <div class="cell-content">
          <div class="reasoning-body collapsed">
            <h3>Step 1 - Identify the genetic tool</h3>
            <p>Striatal cholinergic interneurons (ChINs) are universally targeted using a <strong>ChAT-Cre</strong>
              (choline acetyltransferase promoter-driven Cre) driver line. There is no striatum-restricted cholinergic
              Cre line in common use, so a ChAT-Cre × reporter cross labels <strong>all</strong> ChAT-expressing
              neurons throughout the brain.</p>
            <h3>Step 2 - Which cortical cells also express ChAT?</h3>
            <p>The cortex contains a sparse population of <strong>ChAT-positive interneurons</strong>. These are
              GABAergic interneurons that co-release acetylcholine and would be labeled (&quot;light up&quot;) by any
              ChAT-Cre-driven reporter, even though the experiment was designed to target the striatum.</p>
            <h3>Step 3 - What neuropeptide do cortical ChAT⁺ interneurons express?</h3>
            <p>Cortical ChAT⁺ interneurons are a well-characterized subset of <strong>VIP-expressing (VIP⁺)
                interneurons</strong>. This co-expression has been confirmed by single-cell RNA-seq (e.g., the Allen
              Brain Cell Atlas), ISH, and electrophysiological studies. They belong to the CGE-derived, bipolar/bitufted
              VIP+ class of cortical GABAergic interneurons.</p>
            <h3>Summary</h3>
            <table>
              <thead>
                <tr>
                  <th>Reasoning step</th>
                  <th>Entity</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td>Striatal cholinergic neuron marker</td>
                  <td><em>Chat</em> (ChAT-Cre)</td>
                </tr>
                <tr>
                  <td>Off-target cortical labeling</td>
                  <td>Cortical ChAT⁺ interneurons</td>
                </tr>
                <tr>
                  <td>Neuropeptide co-expressed</td>
                  <td><strong>VIP</strong></td>
                </tr>
              </tbody>
            </table>
            <p>The neuropeptide is <strong>VIP (vasoactive intestinal peptide)</strong>.</p>
          </div>
          <span class="show-toggle">show more</span>
        </div>
      </div>

      <div class="divider-row"></div>

      <div class="cell kg">
        <div class="cell-section-label">Answer</div>
        <div class="cell-content">
          <p>The neuropeptides are Sst (somatostatin) and Npy (neuropeptide Y), with Cort (cortistatin) as a
            notable additional marker.</p>
        </div>
      </div>
      <div class="cell plain">
        <div class="cell-section-label">Answer</div>
        <div class="cell-content">VIP (Vasoactive Intestinal Peptide)
        </div>
      </div>

      <div class="notes-row">
        <div class="notes-label">Observations</div>
        <div class="notes-content">Bla bla</div>
      </div>
    </div>
  </div>

  <!-- QUESTION 6 -->
  <div class="question-block">
    <div class="question-label">Question 6</div>
    <div class="question-text">
      The arcuate Otp+/Npy+ neurons are part of the well-known energy homeostasis circuit and show a strong
      transcriptomic change with healthy ageing. Based on this info, which non-telencephalic region is also supposed to
      change with healthy ageing?
    </div>
    <div class="comparison-grid">
      <div class="col-header kg">Opus KG-mcp</div>
      <div class="col-header plain">Opus Plain</div>

      <div class="cell kg">
        <div class="cell-section-label">Reasoning</div>
        <div class="cell-content">
          <div class="reasoning-body collapsed">
            <p><strong>Step 1 - Identifying the neurons.</strong> The arcuate Otp+/Npy+ neurons correspond to clusters
              1837ÔÇô1838 (<code>TU-ARH Otp Six6 Gaba_1</code>), which co-express <strong>Agrp + Npy</strong> (and
              Cartpt in 1837). These are the canonical <strong>AgRP/NPY orexigenic neurons</strong> of the arcuate
              nucleus - the hunger-promoting arm of the energy homeostasis circuit.</p>
            <p><strong>Step 2 - The circuit.</strong> The &quot;well-known energy homeostasis circuit&quot; centered
              on these neurons is the <strong>ARH ÔåÆ PVH melanocortin circuit</strong>:</p>
            <ul>
              <li>ARH AgRP/NPY neurons project to the PVH, where AgRP antagonizes MC4R and NPY acts on Y1/Y5 receptors
                to promote feeding</li>
              <li>The opposing arm (ARH POMC/CART neurons) activates MC4R in PVH to suppress feeding</li>
              <li>The PVH integrates these signals and controls energy expenditure and feeding behavior via descending
                projections to brainstem autonomic centers (NTS, DMX)</li>
            </ul>
            <p>The database confirms PVH contains Otp+ glutamatergic clusters (PVH-SO-PVa Otp Glut series) expressing
              key neuroendocrine peptides (CRH, TRH, AVP, OXT) - the downstream effector neurons of this circuit.</p>
            <p><strong>Step 3 - Why PVH should also change with ageing.</strong> If presynaptic ARH AgRP/NPY neurons
              undergo strong transcriptomic changes with healthy ageing (altered neuropeptide expression, receptor
              levels, signaling molecules), the PVH neurons they innervate would be expected to show corresponding
              changes through:</p>
            <ul>
              <li>Altered synaptic input and trans-synaptic signaling</li>
              <li>Compensatory receptor regulation (MC4R, Y1R)</li>
              <li>Downstream neuroendocrine adjustments (CRH, TRH axes)</li>
            </ul>
            <h3>Plausibility ranking</h3>
            <table>
              <thead>
                <tr>
                  <th>Rank</th>
                  <th>Region</th>
                  <th>Rationale</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td><strong>1</strong></td>
                  <td><strong>PVH</strong> (Paraventricular hypothalamic nucleus)</td>
                  <td>Primary and most direct target of ARH AgRP/NPY neurons; core node of the melanocortin energy
                    circuit</td>
                </tr>
                <tr>
                  <td>2</td>
                  <td>NTS (Nucleus of the solitary tract)</td>
                  <td>Brainstem node of the energy circuit, receives descending PVH projections and vagal satiety
                    signals</td>
                </tr>
                <tr>
                  <td>3</td>
                  <td>LHA (Lateral hypothalamic area)</td>
                  <td>Secondary ARH projection target (orexin/MCH neurons), but less central to the
                    &quot;well-known&quot; circuit</td>
                </tr>
              </tbody>
            </table>
            <p><strong>Data-supported</strong>: The ARH clusters 1837/1838 are AgRP/NPY/GABA neurons; PVH clusters are
              Otp+ glutamatergic neurons with CRH/TRH - both confirmed in the graph.</p>
            <p><strong>Mechanistic inference</strong>: Circuit-level coupling predicts that transcriptomic ageing
              changes in ARH neurons propagate to their primary postsynaptic target, the PVH.</p>
            <p><strong>Remaining uncertainty</strong>: The database does not contain direct projection or ageing data,
              so the PVH prediction rests on canonical circuit knowledge rather than graph-internal evidence.</p>
          </div>
          <span class="show-toggle">show more</span>
        </div>
      </div>
      <div class="cell plain">
        <div class="cell-section-label">Reasoning</div>
        <div class="cell-content">
          <div class="reasoning-body collapsed">
            <h3>1. The Circuit</h3>
            <p>The arcuate <strong>Otp+/Npy+</strong> neurons are the canonical <strong>NPY/AgRP orexigenic</strong>
              population. The &quot;well-known energy homeostasis circuit&quot; they participate in is the
              <strong>melanocortin pathway</strong>, whose primary downstream target is the <strong>paraventricular
                hypothalamic nucleus (PVH)</strong>.
            </p>
            <p>ARC (NPY/AgRP &amp; POMC) <strong>ÔåÆ</strong> PVH <strong>ÔåÆ</strong> regulation of food intake,
              energy expenditure, and neuroendocrine output</p>
            <h3>2. The Otp Link</h3>
            <p>This is the critical clue. <strong>Otp (Orthopedia)</strong> is a homeodomain transcription factor that
              specifies neuronal identity during development in both the ARC and the PVH. Otp-lineage neurons populate
              both nuclei, meaning they share a developmental program. If Otp+ neurons in the ARC show strong
              transcriptomic drift with healthy ageing, their developmentally related Otp+ counterparts in the
              <strong>PVH</strong> - which are their direct synaptic partners - would be predicted to show
              correlated ageing-related transcriptomic changes as well.
            </p>
            <h3>3. Why PVH Specifically</h3>
            <ul>
              <li><strong>Non-telencephalic</strong>: PVH is diencephalic (hypothalamus) - satisfies the constraint.
              </li>
              <li><strong>Shared Otp developmental origin</strong> with ARC neurons.</li>
              <li><strong>Direct synaptic target</strong> of ARC NPY neurons in the energy homeostasis circuit.</li>
              <li>PVH integrates the orexigenic (NPY/AgRP) and anorexigenic (POMC/CART) signals from the ARC and
                translates them into neuroendocrine and autonomic outputs (e.g., CRH, TRH, oxytocin, vasopressin
                release).</li>
            </ul>
            <h3>Summary</h3>
            <p>If arcuate Otp+/Npy+ neurons change transcriptomically with ageing, the <strong>PVH</strong> - their
              primary circuit partner and developmental sibling via shared Otp lineage - is the non-telencephalic
              region predicted to also change with healthy ageing.</p>

          </div>
          <span class="show-toggle">show more</span>
        </div>
      </div>

      <div class="divider-row"></div>

      <div class="cell kg">
        <div class="cell-section-label">Answer</div>
        <div class="cell-content">
          The non-telencephalic region expected to also change with healthy ageing is the <b>Paraventricular
            hypothalamic nucleus (PVH)</b>
        </div>
      </div>
      <div class="cell plain">
        <div class="cell-section-label">Answer</div>
        <div class="cell-content">
          The Paraventricular Nucleus of the Hypothalamus (PVH)
        </div>
      </div>

      <div class="notes-row">
        <div class="notes-label">Observations</div>
        <div class="notes-content">Both wrong, ground truth was Nucleus Incertus (NI). With a follow up asking about NI
          as possible candidate they both changed their responses accordingly.</div>
      </div>
    </div>
  </div>

  <!-- QUESTION 7 -->
  <div class="question-block">
    <div class="question-label">Question 7</div>
    <div class="question-text">Which anatomical division in the adult mouse brain is the most heterogenous in terms of
      cell type composition?</div>
    <div class="comparison-grid">
      <div class="col-header kg">Opus KG-mcp</div>
      <div class="col-header plain">Opus Plain</div>

      <div class="cell kg">
        <div class="cell-section-label">Reasoning</div>
        <div class="cell-content">
          <div class="reasoning-body collapsed">
            <ul>
              <li>It hosts <strong>719 distinct cell type clusters</strong> (second only to Midbrain in raw count)</li>
              <li>It spans <strong>16 Classes</strong> and <strong>8 Neighborhoods</strong> - the highest diversity at
                both coarse levels among all regions</li>
            </ul>
            <p>While the <strong>Midbrain (MB)</strong> has slightly more clusters (746), its diversity collapses into
              only 5 Neighborhoods compared to the Hypothalamus&#39;s 8, meaning many of those Midbrain clusters are
              variations within fewer broad cell categories.</p>
            <p>The Hypothalamus&#39;s exceptional heterogeneity reflects its role as a hub integrating endocrine,
              autonomic, and behavioral functions - requiring a uniquely diverse repertoire of neuronal and
              non-neuronal cell types.</p>

          </div>
          <span class="show-toggle">show more</span>
        </div>
      </div>
      <div class="cell plain">
        <div class="cell-section-label">Reasoning</div>
        <div class="cell-content">
          <div class="reasoning-body collapsed">
            <p>Based on large-scale single-cell and spatial transcriptomic atlases (Allen Brain Cell Atlas, BICCN), the
              <strong>cerebral cortex</strong> - and more broadly the <strong>telencephalon/cerebrum</strong> -
              harbors the greatest cell-type heterogeneity in the adult mouse brain. Here&#39;s the reasoning:
            </p>
            <h3>Why the cerebral cortex wins in absolute diversity</h3>
            <ul>
              <li><strong>Glutamatergic neurons</strong>: Dozens of layer-specific (L2/3, L4, L5, L6) and area-specific
                (e.g., visual vs. motor vs. prefrontal) excitatory subtypes, creating a combinatorial explosion of
                identities across the cortical sheet.</li>
              <li><strong>GABAergic interneurons</strong>: All major cardinal classes - <strong>Pvalb</strong>,
                <strong>Sst</strong>, <strong>Vip</strong>, <strong>Lamp5</strong>, <strong>Sncg</strong> - each with
                multiple molecularly distinct subtypes, many shared across areas.
              </li>
              <li><strong>Glia</strong>: Full complement of astrocytes, oligodendrocytes, OPCs, and microglia, with
                regional specialization.</li>
              <li><strong>Hippocampal formation</strong> adds further unique types (e.g., CA1/CA3 pyramidal subtypes,
                dentate granule cells).</li>
            </ul>
            <h3>Notable runner-up: The Hypothalamus</h3>
            <p>The <strong>hypothalamus</strong> deserves special mention. Per unit volume, it may be the <em>most
                diverse</em> region, with hundreds of neuron types defined by combinatorial expression of:</p>
            <ul>
              <li>Neuropeptides (Avp, Oxt, Crh, Agrp, Pomc, Hcrt, etc.)</li>
              <li>Transcription factors (Nr5a1, Sim1, Otp, etc.)</li>
              <li>Mixed neurotransmitter identities (glutamatergic, GABAergic, and co-releasing)</li>
            </ul>
            <h3>Summary</h3>
            <table>
              <thead>
                <tr>
                  <th>Division</th>
                  <th>Absolute # of cell types</th>
                  <th>Diversity per volume</th>
                  <th>Key driver</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td><strong>Cerebral cortex</strong></td>
                  <td><strong>Highest</strong></td>
                  <td>High</td>
                  <td>Layer ├ù area ├ù class combinatorics</td>
                </tr>
                <tr>
                  <td><strong>Hypothalamus</strong></td>
                  <td>Very high</td>
                  <td><strong>Highest</strong></td>
                  <td>Neuropeptide/TF combinatorics</td>
                </tr>
                <tr>
                  <td>Cerebral nuclei</td>
                  <td>Moderate</td>
                  <td>Moderate</td>
                  <td>Striatal/pallidal specialization</td>
                </tr>
                <tr>
                  <td>Thalamus</td>
                  <td>Moderate</td>
                  <td>Moderate</td>
                  <td>Nucleus-specific types</td>
                </tr>
                <tr>
                  <td>Midbrain/Hindbrain</td>
                  <td>Moderate</td>
                  <td>Moderate</td>
                  <td>Neuromodulatory diversity</td>
                </tr>
                <tr>
                  <td>Cerebellum</td>
                  <td>Low</td>
                  <td>Low</td>
                  <td>Dominated by granule cells</td>
                </tr>
              </tbody>
            </table>
            <b>Bottom line</b>: The <b>cerebral cortex (isocortex)</b> is the most heterogeneous in total
            cell-type composition, driven by the intersection of laminar, areal, and interneuron diversity. If the
            question is about <em>neuronal subtype density</em>, the <b>hypothalamus</b> is a strong contender.

          </div>
          <span class="show-toggle">show more</span>
        </div>
      </div>

      <div class="divider-row"></div>

      <div class="cell kg">
        <div class="cell-section-label">Answer</div>
        <div class="cell-content">
          The <b>Hypothalamus (HY)</b> stands out as the most heterogeneous anatomical division in terms of cell type
          composition.
        </div>
      </div>
      <div class="cell plain">
        <div class="cell-section-label">Answer</div>
        <div class="cell-content">Most Heterogeneous Anatomical Division: <b>The Cerebral Cortex</b> (Isocortex +
          Allocortex).
        </div>
      </div>

      <div class="notes-row">
        <div class="notes-label">Observations</div>
        <div class="notes-content">Ground truth: Hypothalamus (and midbrain as runner up). Opus-KG cited both</div>
      </div>
    </div>
  </div>

  <!-- QUESTION 8 -->
  <div class="question-block">
    <div class="question-label">Question 8</div>
    <div class="question-text">Which brain anatomical division in the adult mouse brain is the most chemically diverse
      in how its neurons communicate through neurotransmitters?</div>
    <div class="comparison-grid">
      <div class="col-header kg">Opus KG-mcp</div>
      <div class="col-header plain">Opus Plain</div>

      <div class="cell kg">
        <div class="cell-section-label">Reasoning</div>
        <div class="cell-content">
          <div class="reasoning-body collapsed"> Out of 8 total neurotransmitter types in the database (Chol, Dopa,
            GABA, Glut, Glyc, Hist, Nora, Sero), the Pons hosts clusters using 7 of them — every neurotransmitter except
            Histamine. It shares this distinction with two of its sub-nuclei (Laterodorsal tegmental nucleus and Pontine
            central gray).</p>
            <p> The Pons neurotransmitter breakdown across its 386 clusters:</p>
            <table>
              <thead>
                <tr>
                  <th>Neurotransmitter</th>
                  <th>Clusters</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td>GABA</td>
                  <td>171</td>
                </tr>
                <tr>
                  <td>Glutamate</td>
                  <td>167</td>
                </tr>
                <tr>
                  <td>Glycine</td>
                  <td>69</td>
                </tr>
                <tr>
                  <td>Serotonin</td>
                  <td>9</td>
                </tr>
                <tr>
                  <td>Acetylcholine</td>
                  <td>6</td>
                </tr>
                <tr>
                  <td>Dopamine</td>
                  <td>2</td>
                </tr>
                <tr>
                  <td>Noradrenaline</td>
                  <td>1</td>
                </tr>
              </tbody>
            </table>
            <p> This chemical diversity reflects the Pons&#39;s role as a brainstem relay station integrating motor,
              sensory, autonomic, and modulatory functions — requiring the full spectrum of
              classical neurotransmitter systems.</p>
          </div>
          <span class="show-toggle">show more</span>
        </div>
      </div>
      <div class="cell plain">
        <div class="cell-section-label">Reasoning</div>
        <div class="cell-content">
          <div class="reasoning-body collapsed">
            <p>Here&#39;s the systematic reasoning:</p>
            <h3>Why the hypothalamus wins</h3>
            <p><strong>1. Neurotransmitter multiplexing</strong>
              Hypothalamic neurons routinely co-release multiple classical neurotransmitters - many nuclei contain
              neurons that are simultaneously glutamatergic and GABAergic, or switch transmitter identity in a
              state-dependent manner. This degree of co-transmission is unmatched elsewhere.</p>
            <p><strong>2. Neuropeptide diversity</strong>
              The hypothalamus expresses the largest repertoire of neuropeptides of any brain region, including:</p>
            <ul>
              <li><strong>Feeding/metabolism</strong>: Agrp, Npy, Pomc, Cart, Hcrt/Orexin, Mch, Ghrh</li>
              <li><strong>Stress/HPA axis</strong>: Crh, Avp, Oxt</li>
              <li><strong>Reproduction</strong>: GnRH, Kisspeptin (Kiss1), Tac2</li>
              <li><strong>Thermoregulation/sleep</strong>: Galanin (Gal), Pacap, Vip, Prok2</li>
              <li><strong>Social behavior</strong>: Oxytocin, Vasopressin</li>
            </ul>
            <p>Many single neurons express <strong>3ÔÇô5+ neuropeptides simultaneously</strong>, creating a
              combinatorial chemical code far richer than classical neurotransmitter identity alone.</p>
            <p><strong>3. Monoamine and other small-molecule signals</strong>
              The hypothalamus contains or receives dense input from <strong>histaminergic</strong> (tuberomammillary
              nucleus - the sole source of brain histamine), <strong>dopaminergic</strong> (tuberoinfundibular,
              A11ÔÇôA14 groups), and <strong>serotonin-sensitive</strong> populations.</p>
            <p><strong>4. Neurohormonal signaling</strong>
              Uniquely, hypothalamic neurons also function as <strong>neuroendocrine cells</strong>, releasing peptides
              directly into the portal vasculature and bloodstream - a chemical communication modality absent from
              other divisions.</p>
            <h3>Comparison across divisions</h3>
            <table>
              <thead>
                <tr>
                  <th>Division</th>
                  <th>Classical NTs</th>
                  <th>Neuropeptide diversity</th>
                  <th>Co-transmission</th>
                  <th>Neurohormonal</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td><strong>Hypothalamus</strong></td>
                  <td><strong>Glu + GABA + mixed</strong></td>
                  <td><strong>Highest (~50+ peptides)</strong></td>
                  <td><strong>Extensive</strong></td>
                  <td><strong>Yes</strong></td>
                </tr>
                <tr>
                  <td>Midbrain/Hindbrain</td>
                  <td>Glu, GABA, DA, 5-HT, NE</td>
                  <td>Moderate</td>
                  <td>Moderate</td>
                  <td>No</td>
                </tr>
                <tr>
                  <td>Cerebral cortex</td>
                  <td>Glu, GABA</td>
                  <td>LowÔÇômoderate</td>
                  <td>Limited</td>
                  <td>No</td>
                </tr>
                <tr>
                  <td>Thalamus</td>
                  <td>Glu, GABA</td>
                  <td>Low</td>
                  <td>Minimal</td>
                  <td>No</td>
                </tr>
                <tr>
                  <td>Cerebellum</td>
                  <td>Glu, GABA</td>
                  <td>Very low</td>
                  <td>Minimal</td>
                  <td>No</td>
                </tr>
                <tr>
                  <td>Cerebral nuclei</td>
                  <td>Glu, GABA, ACh, DA</td>
                  <td>Moderate</td>
                  <td>Moderate</td>
                  <td>No</td>
                </tr>
              </tbody>
            </table>
            <h3>Key distinction from the previous question</h3>
            <p>The cerebral cortex wins on <strong>cell-type heterogeneity</strong> (driven by laminar/areal
              combinatorics), but its neurons communicate through a relatively narrow chemical palette (primarily
              glutamate and GABA). The hypothalamus, by contrast, achieves its diversity through <strong>chemical
                identity</strong> - the sheer number of distinct signaling molecules deployed per neuron and per
              nucleus is unparalleled.</p>
            <p><strong>Bottom line</strong>: The <strong>hypothalamus</strong> is the most chemically diverse division,
              uniquely combining classical neurotransmitters, extensive co-transmission, the brain&#39;s richest
              neuropeptide repertoire, and neuroendocrine signaling into the vasculature.</p>
          </div>
          <span class="show-toggle">show more</span>
        </div>
      </div>

      <div class="divider-row"></div>

      <div class="cell kg">
        <div class="cell-section-label">Answer</div>
        <div class="cell-content">
          The Pons (P) is the most chemically diverse brain division in terms of neurotransmitter communication.
        </div>
      </div>
      <div class="cell plain">
        <div class="cell-section-label">Answer</div>
        <div class="cell-content">
          The <b>Hypothalamus</b> is the most chemically diverse brain division in terms of neurotransmitter and
          neuromodulatory signaling.
        </div>
      </div>

      <div class="notes-row">
        <div class="notes-label">Observations</div>
        <div class="notes-content">ground truth: Brainstem -> Pons and Midbrain</div>
      </div>
    </div>
  </div>
  <!-- QUESTION 9 -->
  <div class="question-block">
    <div class="question-label">Question 9</div>
    <div class="question-text">
      Which single neuropeptide is expressed most frequently across all rare-transmitter neuron clusters, and which
      brain regions contain it?
    </div>
    <div class="comparison-grid">
      <div class="col-header kg">Opus KG-mcp</div>
      <div class="col-header plain">Opus Plain</div>

      <div class="cell kg">
        <div class="cell-section-label">Reasoning</div>
        <div class="cell-content">
          <div class="reasoning-body collapsed">
            <p><strong>Rare-transmitter clusters</strong> (neurotransmitter associated with &lt;200 clusters): Histamine
              (5), Noradrenaline (12), Serotonin (20), Acetylcholine (48), and Dopamine (67) - totaling 152 clusters.
            </p>
            <p>Adcyap1 expression spans all rare transmitter systems except histamine:</p>
            <table>
              <thead>
                <tr>
                  <th>Neurotransmitter</th>
                  <th>Clusters with Adcyap1</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td>Dopamine</td>
                  <td>21</td>
                </tr>
                <tr>
                  <td>Cholinergic</td>
                  <td>13</td>
                </tr>
                <tr>
                  <td>Serotonin</td>
                  <td>6</td>
                </tr>
                <tr>
                  <td>Noradrenaline</td>
                  <td>5</td>
                </tr>
              </tbody>
            </table>
            <p><strong>Key brain regions</strong> harboring these Adcyap1+ rare-transmitter clusters:</p>
            <ul>
              <li><strong>Midbrain</strong> (MB) - 17 clusters, dominated by dopaminergic VTA/SN neurons</li>
              <li><strong>Ventral tegmental area</strong> (VTA) - 10 clusters</li>
              <li><strong>Raphe nuclei</strong> (IF, CLI, DR, RL) - serotonergic hubs</li>
              <li><strong>Pons</strong> (P) - 7 clusters, including noradrenergic locus coeruleus projections</li>
              <li><strong>Hypothalamus</strong> (HY, SUM, PH) - mixed modulatory populations</li>
              <li><strong>Brainstem visceral nuclei</strong> (NTS, DMX, PB) - cholinergic/noradrenergic autonomic
                centers</li>
              <li><strong>Interpeduncular nucleus</strong> (IPA, IPDM, IPDL) - habenulo-interpeduncular circuit</li>
            </ul>
            <p>This is biologically coherent: PACAP is a pleiotropic neuropeptide with well-established roles in stress
              responses, autonomic regulation, and neuromodulation. It is broadly co-expressed in monoaminergic and
              cholinergic systems throughout the brainstem and midbrain - precisely the cell populations that define
              the rare-transmitter landscape.</p>
            <h2>Doubts</h2>
            <ul>
              <li>Histamine clusters (only 5) express no Adcyap1, but the sample is very small and histaminergic neurons
                in the tuberomammillary nucleus have been reported to co-express PACAP in some studies, so absence here
                may reflect detection thresholds rather than true biology.</li>
              <li>The <code>Has_np_marker</code> relationship captures statistically enriched markers, so Adcyap1 may be
                expressed at low levels in additional clusters not captured by this edge type.</li>
            </ul>

          </div>
          <span class="show-toggle">show more</span>
        </div>
      </div>
      <div class="cell plain">
        <div class="cell-section-label">Reasoning</div>
        <div class="cell-content">
          <div class="reasoning-body collapsed">
            <h3>Why Galanin?</h3>
            <p>Rare-transmitter neurons - those using transmitters other than glutamate or GABA (cholinergic,
              serotonergic, dopaminergic, noradrenergic, histaminergic) - are scattered across the brain. <em>Gal</em>
              uniquely co-occurs with multiple rare-transmitter systems:</p>
            <table>
              <thead>
                <tr>
                  <th>Rare-transmitter system</th>
                  <th>Key marker</th>
                  <th><em>Gal</em> co-expression</th>
                  <th>Brain region</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td><strong>Noradrenergic</strong></td>
                  <td><em>Dbh</em> / <em>Th</em></td>
                  <td>Strong</td>
                  <td>Locus coeruleus (pons)</td>
                </tr>
                <tr>
                  <td><strong>Cholinergic</strong></td>
                  <td><em>Chat</em></td>
                  <td>Strong</td>
                  <td>Basal forebrain (medial septum, diagonal band)</td>
                </tr>
                <tr>
                  <td><strong>Histaminergic</strong></td>
                  <td><em>Hdc</em></td>
                  <td>Present</td>
                  <td>Tuberomammillary nucleus (hypothalamus)</td>
                </tr>
                <tr>
                  <td><strong>Serotonergic</strong></td>
                  <td><em>Tph2</em> / <em>Slc6a4</em></td>
                  <td>Subset</td>
                  <td>Dorsal raphe (midbrain)</td>
                </tr>
                <tr>
                  <td><strong>Hypothalamic neuroendocrine</strong></td>
                  <td>Various</td>
                  <td>Widespread</td>
                  <td>Arcuate, MPOA, lateral hypothalamus</td>
                </tr>
              </tbody>
            </table>
            <h3>Brain regions containing Galanin-expressing rare-transmitter neurons</h3>
            <ol>
              <li><strong>Hypothalamus</strong> - tuberomammillary nucleus (histaminergic), arcuate/preoptic area
                (neuroendocrine)</li>
              <li><strong>Pons</strong> - locus coeruleus (noradrenergic)</li>
              <li><strong>Basal forebrain</strong> - medial septum &amp; diagonal band of Broca (cholinergic)</li>
              <li><strong>Midbrain</strong> - dorsal raphe nucleus (serotonergic subsets)</li>
            </ol>
            <h3>Biological rationale</h3>
            <p>Galanin acts as a modulatory co-transmitter that fine-tunes the release and postsynaptic effects of the
              primary transmitter. Its recurring presence across rare-transmitter systems reflects a conserved role in
              <strong>gain control and homeostatic regulation</strong> - particularly in circuits governing arousal,
              stress, feeding, and autonomic function, which are precisely the circuits where rare-transmitter neurons
              concentrate.
            </p>


          </div>
          <span class="show-toggle">show more</span>
        </div>
      </div>

      <div class="divider-row"></div>

      <div class="cell kg">
        <div class="cell-section-label">Answer</div>
        <div class="cell-content">
          <b>Adcyap1</b> (encoding the neuropeptide <b>PACAP</b> - Pituitary Adenylate Cyclase-Activating Polypeptide)
          is the single neuropeptide most frequently expressed across rare-transmitter neuron clusters, present in <b>45
            out of 152</b> such clusters.
        </div>
      </div>
      <div class="cell plain">
        <div class="cell-section-label">Answer</div>
        <div class="cell-content">
          Answer: <b>Galanin</b> (Gal)
          <b>Galanin</b> is the single neuropeptide expressed most frequently across rare-transmitter neuron clusters in
          the adult mouse brain.
        </div>
      </div>

      <div class="notes-row">
        <div class="notes-label">Observations</div>
        <div class="notes-content">Ground truth: Adcyap1 (PACAP)</div>
      </div>
    </div>
  </div>

  <!-- QUESTION 10 -->
  <div class="question-block">
    <div class="question-label">Question 10</div>
    <div class="question-text">
      Which rare-transmitter neurons have the most exclusive neuropeptide signature (NPs found almost nowhere else)?
    </div>
    <div class="comparison-grid">
      <div class="col-header kg">Opus KG-mcp</div>
      <div class="col-header plain">Opus Plain</div>

      <div class="cell kg">
        <div class="cell-section-label">Reasoning</div>
        <div class="cell-content">
          <div class="reasoning-body collapsed">
            <p>The rare-transmitter clusters with the <strong>most exclusive neuropeptide signatures</strong> fall into
              three distinct groups, ranked by exclusivity:</p>
            <h3>1. Brainstem noradrenergic &amp; cholinergic clusters - <strong>Uts2b</strong> (3 clusters total in
              the entire brain)</h3>
            <table>
              <thead>
                <tr>
                  <th>Cluster</th>
                  <th>Transmitter</th>
                  <th>Subclass</th>
                  <th>Key Regions</th>
                  <th>NP signature</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td>4548 NTS Dbh Glut_4</td>
                  <td><strong>Nora</strong></td>
                  <td>NTS Dbh Glut</td>
                  <td>Barrington&#39;s nucleus, pontine tegmentum</td>
                  <td>Uts2b, Pomc, Adcyap1, Gal, Calca</td>
                </tr>
                <tr>
                  <td>4552 DMX VII Tbx20 Chol_1</td>
                  <td><strong>Chol</strong></td>
                  <td>DMX VII Tbx20 Chol</td>
                  <td>DMX, NTS</td>
                  <td>Uts2b, Pomc, Gal, Adcyap1</td>
                </tr>
                <tr>
                  <td>4870 MY Lhx1 Gly-Gaba_1</td>
                  <td><strong>Chol</strong></td>
                  <td>MY Lhx1 Gly-Gaba</td>
                  <td>Gigantocellular/magnocellular reticular</td>
                  <td>Uts2b (sole NP)</td>
                </tr>
              </tbody>
            </table>
            <p><strong>Uts2b</strong> (Urotensin-2B) is expressed in <strong>only 3 clusters in the entire
                dataset</strong>, all of which are rare-transmitter neurons. This is 100% exclusivity - the most
              exclusive neuropeptide signature of any group. These are autonomic-associated brainstem populations
              (NTS-noradrenergic and vagal-cholinergic circuits).</p>
            <h3>2. NTS noradrenergic cluster - <strong>Prlh</strong> (2 clusters total)</h3>
            <table>
              <thead>
                <tr>
                  <th>Cluster</th>
                  <th>Transmitter</th>
                  <th>Key Regions</th>
                  <th>NP signature</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td>4535 NTS Dbh Glut_2</td>
                  <td><strong>Nora</strong></td>
                  <td>NTS, Medulla</td>
                  <td><strong>Prlh</strong>, Pomc, Cartpt</td>
                </tr>
              </tbody>
            </table>
            <p><strong>Prlh</strong> (Prolactin-Releasing Hormone) exists in only 2 clusters brain-wide. This NTS
              noradrenergic neuron co-expresses Pomc and Cartpt - a signature consistent with <strong>A2/C2
                catecholaminergic</strong> neurons involved in satiety signaling and stress-related autonomic
              regulation.</p>
            <h3>3. Midbrain dopaminergic clusters - <strong>Npw</strong> (5 clusters total, 4 are rare-transmitter)
            </h3>
            <table>
              <thead>
                <tr>
                  <th>Cluster</th>
                  <th>Transmitter</th>
                  <th>Key Regions</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td>3845 SNc-VTA-RAmb Foxa1 Dopa_2</td>
                  <td><strong>Dopa</strong></td>
                  <td>VTA, CLI, supramammillary</td>
                </tr>
                <tr>
                  <td>3861 SNc-VTA-RAmb Foxa1 Dopa_4</td>
                  <td><strong>Dopa</strong></td>
                  <td>Dorsal raphe, PAG</td>
                </tr>
                <tr>
                  <td>3869 SNc-VTA-RAmb Foxa1 Dopa_5</td>
                  <td><strong>Dopa</strong></td>
                  <td>PAG, VTA</td>
                </tr>
                <tr>
                  <td>3876 SNc-VTA-RAmb Foxa1 Dopa_7</td>
                  <td><strong>Dopa</strong></td>
                  <td>VTA, interfascicular raphe</td>
                </tr>
              </tbody>
            </table>
            <p>All belong to the <strong>SNc-VTA-RAmb Foxa1 Dopa</strong> subclass. <strong>Npw</strong> (Neuropeptide
              W) is expressed in only 5 clusters, of which 4 are these dopaminergic neurons. Npw+Cck co-expression marks
              a molecularly distinct VTA dopamine subpopulation, potentially involved in reward modulation circuits
              distinct from canonical VTA-DA neurons.</p>
            <h3>Honorable mention: HB Calcb Chol - <strong>Calcb + Agrp</strong> combination</h3>
            <p>Five <strong>hindbrain cholinergic</strong> motor-neuron clusters (cranial motor nuclei: trigeminal,
              facial, abducens, oculomotor, hypoglossal, DMX) share the unusual combination of <strong>Calcb</strong>
              (11 clusters total) and <strong>Agrp</strong> (24 clusters total). While neither NP is individually
              ultra-rare, their co-expression in cholinergic motor neurons is highly distinctive - Agrp is classically
              associated with hypothalamic hunger circuits, making its expression in brainstem motor neurons a notable
              molecular curiosity.</p>
            <h2>Explanation</h2>
            <p>Exclusivity was measured as the fraction of all clusters expressing a given neuropeptide that belong to
              rare-transmitter populations. The top-ranked neuropeptides (Uts2b, Prlh, Npw) are all concentrated in
              <strong>brainstem autonomic/modulatory circuits</strong> - a theme consistent with the biology: rare
              transmitter systems (noradrenaline, acetylcholine, dopamine) are themselves enriched in brainstem and
              midbrain, and their most exclusive peptide co-transmitters tend to mark specialized functional
              subpopulations within these systems (visceral control, stress, reward).
            </p>
            <h2>Doubts</h2>
            <ul>
              <li><strong>Uts2b</strong> in cluster 4870 (the sole NP) could reflect a marker detection artifact -
                having only one neuropeptide may indicate low overall neuropeptide expression rather than a truly
                exclusive signature.</li>
              <li><strong>Agrp</strong> in cranial motor neurons (HB Calcb Chol) is unexpected. It could represent
                ectopic low-level expression picked up by the marker algorithm, or a genuine non-canonical Agrp function
                outside the arcuate nucleus. This warrants caution.</li>
              <li>The exclusivity metric is sensitive to marker detection thresholds: a neuropeptide barely missing the
                cutoff in glutamatergic/GABAergic clusters would appear artificially exclusive to rare-transmitter
                populations.</li>
            </ul>
          </div>
          <span class="show-toggle">show more</span>
        </div>
      </div>
      <div class="cell plain">
        <div class="cell-section-label">Reasoning</div>
        <div class="cell-content">
          <div class="reasoning-body collapsed">
            <p>These neurons possess the most exclusive neuropeptide signature among all rare-transmitter populations
              - their defining neuropeptide combination is virtually absent from other cell types.</p>
            <hr>
            <h3>The exclusive signature</h3>
            <table>
              <thead>
                <tr>
                  <th>Neuropeptide</th>
                  <th>Found in HDC+ TMN neurons</th>
                  <th>Found broadly elsewhere?</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td><strong>Hdc</strong> (histamine-synthesizing enzyme)</td>
                  <td>Defining marker</td>
                  <td>No - nearly unique to TMN</td>
                </tr>
                <tr>
                  <td><strong>Penk</strong> (proenkephalin)</td>
                  <td>Co-expressed</td>
                  <td>Yes - widespread</td>
                </tr>
                <tr>
                  <td><strong>Gal</strong> (galanin)</td>
                  <td>Co-expressed</td>
                  <td>Yes - widespread</td>
                </tr>
                <tr>
                  <td><strong>Cartpt</strong> (CART)</td>
                  <td>Subset</td>
                  <td>Moderate - hypothalamus, VTA</td>
                </tr>
                <tr>
                  <td><strong>Pmch</strong> (MCH)</td>
                  <td>Neighboring but overlapping</td>
                  <td>Narrow - lateral hypothalamus</td>
                </tr>
              </tbody>
            </table>
            <p>The critical distinction: <strong>no other neuron cluster co-expresses <em>Hdc</em> + <em>Gal</em> +
                <em>Penk</em> together</strong>. While individual peptides appear elsewhere, the combinatorial
              signature is essentially private to this population.</p>
            <hr>
            <h3>Runners-up, ranked by exclusivity</h3>
            <table>
              <thead>
                <tr>
                  <th>Rank</th>
                  <th>Rare-transmitter type</th>
                  <th>Near-exclusive NP features</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td><strong>2</strong></td>
                  <td><strong>Noradrenergic (LC)</strong></td>
                  <td><em>Gal</em> + <em>Npy</em> + <em>Dbh</em> combination is highly restricted to the locus
                    coeruleus; few other clusters share all three</td>
                </tr>
                <tr>
                  <td><strong>3</strong></td>
                  <td><strong>Serotonergic (dorsal raphe)</strong></td>
                  <td>Subcluster-specific peptides like <em>Nps</em> (neuropeptide S) in some DRN subsets are quite
                    rare, but serotonergic neurons overall share many NPs with hypothalamic populations</td>
                </tr>
                <tr>
                  <td><strong>4</strong></td>
                  <td><strong>Cholinergic (basal forebrain)</strong></td>
                  <td>Least exclusive - <em>Gal</em>, <em>Penk</em>, <em>Tac1</em> are all broadly expressed in
                    other systems</td>
                </tr>
              </tbody>
            </table>
            <hr>
            <h3>Why histaminergic neurons are so exclusive</h3>
            <ol>
              <li><strong>Tiny population</strong> - Only ~3,000ÔÇô4,000 HDC+ neurons exist in the entire mouse
                brain, confined to the posterior hypothalamus (TMN / E2 mammillary region)</li>
              <li><strong>Singular developmental origin</strong> - They derive from a narrow progenitor domain,
                retaining a transcriptional program shared by no other mature neuron type</li>
              <li><strong>Functional isolation</strong> - They serve as the sole source of neuronal histamine,
                requiring a unique regulatory neuropeptide milieu for wake-promoting and metabolic functions</li>
              <li><strong>Low transcriptomic diversity</strong> - Unlike serotonergic or cholinergic populations,
                HDC+ neurons form very few subclusters, meaning their NP signature is highly conserved within the
                group and divergent from everything outside it</li>
            </ol>
            <hr>
            <h3>Key takeaway</h3>
            <p>Exclusivity of neuropeptide signature scales inversely with population size and spatial distribution.
              The TMN histaminergic neurons - small, spatially confined, developmentally distinct - sit at the
              extreme end of this spectrum, making their neuropeptide fingerprint the most &quot;private&quot; among
              rare-transmitter classes.</p>
          </div>
          <span class="show-toggle">show more</span>
        </div>
      </div>

      <div class="divider-row"></div>

      <div class="cell kg">
        <div class="cell-section-label">Answer</div>
        <div class="cell-content">Brainstem <b>noradrenergic & cholinergic</b> clusters - Uts2b (3 clusters total in
          the entire brain)
        </div>
      </div>
      <div class="cell plain">
        <div class="cell-section-label">Answer</div>
        <div class="cell-content"><b>Histaminergic (HDC+) neurons</b> of the tuberomammillary nucleus
        </div>
      </div>

      <div class="notes-row">
        <div class="notes-label">Observations</div>
        <div class="notes-content">Ground truth: Cholinergic neurons</div>
      </div>
    </div>
  </div>
  <script>
    (function () {
      function closest(el, selector) {
        while (el && el.nodeType === 1) {
          if (el.matches(selector)) return el;
          el = el.parentElement;
        }
        return null;
      }

      function setToggleText(grid, expanded) {
        var toggles = grid.querySelectorAll('.show-toggle');
        for (var i = 0; i < toggles.length; i++) {
          toggles[i].textContent = expanded ? 'show less' : 'show more';
        }
      }

      function setBodiesCollapsed(grid, collapsed) {
        var bodies = grid.querySelectorAll('.reasoning-body');
        for (var i = 0; i < bodies.length; i++) {
          if (collapsed) bodies[i].classList.add('collapsed');
          else bodies[i].classList.remove('collapsed');
        }
      }

      // Safari-friendly scrollTo target inside a question block
      function scrollBackToReasoning(questionBlock) {
        var target =
          questionBlock.querySelector('.question-text') ||
          questionBlock.querySelector('.question-label') ||
          questionBlock;

        var rect = target.getBoundingClientRect();
        var y = rect.top + window.pageYOffset - 16; // small breathing room
        window.scrollTo({ top: y, behavior: 'smooth' });
      }

      document.querySelectorAll('.show-toggle').forEach(function (toggle) {
        toggle.addEventListener('click', function (e) {
          var grid = closest(toggle, '.comparison-grid');
          if (!grid) return;

          // Determine current state from first reasoning body in this grid
          var firstBody = grid.querySelector('.reasoning-body');
          if (!firstBody) return;

          var currentlyCollapsed = firstBody.classList.contains('collapsed');
          var willExpand = currentlyCollapsed; // if collapsed -> expand; else collapse

          // If we are collapsing, capture where to return BEFORE layout changes
          var questionBlock = closest(grid, '.question-block');

          // Apply synchronized state
          setBodiesCollapsed(grid, !willExpand);
          setToggleText(grid, willExpand);

          // After collapsing, bring viewport back to the question/reasoning area
          if (!willExpand && questionBlock) {
            // wait a frame so the DOM/layout updates (works well in Safari)
            requestAnimationFrame(function () {
              scrollBackToReasoning(questionBlock);
            });
          }
        });
      });
    })();
  </script>

</body>

</html>
